SEARCH

SEARCH BY CITATION

If you wish to receive credit for this activity, please refer to the website: http://www.wileyblackwellcme.com

Accreditation and Designation Statement:

  1. Top of page
  2. Accreditation and Designation Statement:
  3. Educational Objectives
  4. Activity Disclosures
  5. Instructions on Receiving Credit
  6. Follow these steps to earn credit:

Blackwell Futura Media Services designates this educational activity for 13.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Educational Objectives

  1. Top of page
  2. Accreditation and Designation Statement:
  3. Educational Objectives
  4. Activity Disclosures
  5. Instructions on Receiving Credit
  6. Follow these steps to earn credit:

Upon completion of the educational activity, the participant will be better able to:

  •  Articulate the pathophysiology of volume overload in heart failure, renal function in heart failure, and the relationship between hyponatremia and heart failure.
  •  Identify clinical scenarios in which the use of biomarkers may contribute to an early diagnosis of cardiorenal syndrome and to a timely therapeutic intervention.
  •  Utilize current and emerging techniques of fluid status assessment in the course of patient diagnosis.
  •  Develop appropriate treatment and management regimens for congestive heart failure that will not contribute to the worsening of renal dysfunction.

Activity Disclosures

  1. Top of page
  2. Accreditation and Designation Statement:
  3. Educational Objectives
  4. Activity Disclosures
  5. Instructions on Receiving Credit
  6. Follow these steps to earn credit:

The following contributors have no conflicts of interest to disclose:

Pamela Taub, MD; Paulette Gabbaii, MD; Goh Ching Yang, MD; Mitchell Rosner, MD; A D’Onofrio, MD; A Fabbri, MD; G. Cresce, MD; S. Auriemma, MD; I Bolgan, MD; Jeffrey Chan, MD; Salvatore Di Somma, MD; Enrico Ferri, MD; Barbara Alfei, MD; Benedetta De Berardinis, MD; Cristina Bongiovanni, MD; Rossella Marino, MD; Sonal Sakariya, MD; Karina M. Soto-Ruiz, MD;

Alan Maisel, MD discloses the following: Research grants from Nanosphere, Abbott, and Inverness; serves on the Speakers’ Bureau of Inverness and Abbott; and has received honoraria from Inverness.

Claudio Ronco, MD discloses the following: Serves as Speaker for Abbott; received honoraria from Gambro and Inverness.

Dina N. Cruz, MD, MPH discloses the following: Serves as Speaker and has received honoraria from Biosite and Inverness.

Anja Haase-Fielitz, MD discloses the following: Serves as Speaker for Abbott and Biosite and received honoraria from both companies.

Michael Haase, MD discloses the following: Honoraria for lectures for Abbott and Biosite.

Steven Goldsmith, MD discloses the following: Serves as a speaker and consultant for Otsuka and Astellas; received grant support from Astellas.

W. Frank Peacock, MD discloses the following: Research grants from Abbott, BAS, Biosite, Brahms, Inverness, Nanosphere, EKR, and The Medicines Company; Scientific Advisory Board participation for Abbott, Beckman-Coulter, Biosite, Inverness and The Medicines Company; and serves on the Speakers’ Bureau of Abbott and Biosite. He has ownership interest in Vital Sensors.

G. Michael Felker, MD discloses the following: Serves as a consultant for Amgen, Corthera, Roche Diagnostics, Geron, Otsuka, and Cytokinetics

Ken McDonald, MD is a member of the Advisory Board of EFG Diagnostics Ltd, Belfast, Ireland.

Peter S. Pang, MD discloses the following: Research support from Merck and PDL BioPharma; serves as a consultant for Astellas, Bayer, Johnson & Johnson, The Medicines Company, Palatin Technologies, Pericor Therapeutics, and Solvay Pharmaceuticals; and received honoraria for advisory roles from BiogenIdec, Corthera, Ikaria, and Nile Therapeutics

Philip D. Levy, MD discloses the following: Serves as a consultant for The Medicines Company (DSMB), Corthera, Inc., and Bayer Shering AG Steering Committee; received grant funding from The Robert Wood Johnson Foundation Physician Faculty Scholars Program, NIH Loan Repayment Program, The Cleveland Clinic Foundation, Nile Therapeutics, Astellas Pharma, Inc., Corthera, Inc., Solvay Pharmaceuticals, Inc., and Bayer Schering AG; and received an honorarium as a speaker for The Society of Chest Pain Centers.

Nils G. Morgenthaler, MD discloses the following: Salary as employee of Brahms (Germany).

Instructions on Receiving Credit

  1. Top of page
  2. Accreditation and Designation Statement:
  3. Educational Objectives
  4. Activity Disclosures
  5. Instructions on Receiving Credit
  6. Follow these steps to earn credit:

For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within 13.0 hours; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity during the valid credit period, which is up to two years from initial publication.

Follow these steps to earn credit:

  1. Top of page
  2. Accreditation and Designation Statement:
  3. Educational Objectives
  4. Activity Disclosures
  5. Instructions on Receiving Credit
  6. Follow these steps to earn credit:
  • Read the target audience, educational objectives, and activity disclosures.
  • Read the articles in print or online format.
  • Reflect on the articles.
  • Access the CME Exam, and choose the best answer to each question.
  • Complete the required evaluation component of the activity